Log in to save to my catalogue

Pretreatment with P2Y[sub.12] Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpo...

Pretreatment with P2Y[sub.12] Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A750301428

Pretreatment with P2Y[sub.12] Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?

About this item

Full title

Pretreatment with P2Y[sub.12] Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?

Publisher

MDPI AG

Journal title

Journal of clinical medicine, 2023-03, Vol.12 (6)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Excessive platelet reactivity plays a pivotal role in the pathogenesis of acute myocardial infarction. Today, the vast majority of patients presenting with acute coronary syndromes qualify for invasive treatment strategy and thus require fast and efficient platelet inhibition. Since 2008, in cases of ST-elevation myocardial infarction, the European...

Alternative Titles

Full title

Pretreatment with P2Y[sub.12] Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A750301428

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A750301428

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm12062374

How to access this item